The DOI matches its Crossref record; 502 of the 507 references it cites were found in a registry or an index.
The Melanocortin-4 Receptor: Physiology, Pharmacology, and Pathophysiology
Open accessAbstract
The melanocortin-4 receptor (MC4R) was cloned in 1993 by degenerate PCR; however, its function was unknown. Subsequent studies suggest that the MC4R might be involved in regulating energy homeostasis. This hypothesis was confirmed in 1997 by a series of seminal studies in mice. In 1998, human genetic studies demonstrated that mutations in the MC4R gene can cause monogenic obesity. We now know that mutations in the MC4R are the most common monogenic form of obesity, with more than 150 distinct mutations reported thus far. This review will summarize the studies on the MC4R, from its cloning and tissue distribution to its physiological roles in regulating energy homeostasis, cachexia, cardiovascular function, glucose and lipid homeostasis, reproduction and sexual function, drug abuse, pain perception, brain inflammation, and anxiety. I will then review the studies on the pharmacology of the receptor, including ligand binding and receptor activation, signaling pathways, as well as its regulation. Finally, the pathophysiology of the MC4R in obesity pathogenesis will be reviewed. Functional studies of the mutant MC4Rs and the therapeutic implications, including small molecules in correcting binding and signaling defect, and their potential as pharmacological chaperones in rescuing intracellularly retained mutants, will be highlighted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Hyperphagia and increased adiposity lead to stimulation of POMC neurons and MC4R signalling, whereas energy deficits and weight loss reduce signalling in this pathway191,192.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [191]
In the citing paper
“In the ARC and brainstem, POMC-expressing neurons project to second-order neurons involved in BP regulation (for example, in the paraventricular nucleus (PVN)), where their axons release a-melanocyte-stimulating hormone (aMSH), the endogenous ligand for MC4R191 (FIG. 5a).”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [191]
In the citing paper
“The POMC-MC4R system is a major regulator of energy balance.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [191]
In the citing paper
“MC4R signals mainly through phosphorylation of cAMP and activation of protein kinase A (PKA)191.”
From Obesity, kidney dysfunction and hypertension: mechanistic links (2019) · cites this paper as [191]
In the citing paper
“The MC4R is a G protein-coupled 7 transmembrane receptor that increases cAMP phosphorylation and activates protein kinase A (PKA) [3, 26, 63]; therefore, blockade of these intracellular pathways attenuates MC4R actions [3, 63].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [3]
In the citing paper
“The MC4R is a G protein-coupled 7 transmembrane receptor that increases cAMP phosphorylation and activates protein kinase A (PKA) [3, 26, 63]; therefore, blockade of these intracellular pathways attenuates MC4R actions [3, 63].”
From Role of the brain melanocortins in blood pressure regulation (2017) · cites this paper as [3]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–502 of 502
Macronutrient Diet Intake of the Lethal Yellow Agouti (Ay/a) Mouse
Koegler, F. H., Schaffhauser, A. O., Mynatt, R. L., York, D. A., & Bray, G. A. (1999) · Physiology & Behavior · doi:10.1016/s0031-9384(99)00104-3 · Cited by 47
Chai, B., Li, J.-Y., Zhang, W., Wang, H., & Mulholland, M. W. (2009) · Peptides · doi:10.1016/j.peptides.2009.03.006 · Cited by 47
Transgenic MSH overexpression attenuates the metabolic effects of a high-fat diet
Lee, M., Kim, A. D., Chua, S. C., Obici, S., & Wardlaw, S. L. (2007) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00555.2006 · Cited by 47
Archer, Z. A., Findlay, P. A., McMillen, S. R., Rhind, S., & Adam, C. (2004) · Journal of Endocrinology · doi:10.1677/joe.0.1820409 · Cited by 47
da Silva, A. A., do Carmo, J. M., Freeman, J. N., Tallam, L. S., & Hall, J. E. (2009) · Diabetes · doi:10.2337/db08-1221 · Cited by 47
Jónsson, L., Skarphedinsson, J. O., Skúladóttir, G. V., Watanobe, H., & Schiöth, H. B. (2002) · Journal of Endocrinology · doi:10.1677/joe.0.1730517 · Cited by 47
Starowicz, K., Przewłocki, R., Gispen, W. H., & Przewłocka, B. (2002) · Neuroreport · doi:10.1097/00001756-200212200-00015 · Cited by 46
Functions of acidic transmembrane residues in human melanocortin-3 receptor binding and activation
Shu-xiu, W., Fan, Z., & Tao, Y. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.05.026 · Cited by 46
Self-citationContribution of Melanocortin Receptor Exoloops to Agouti-related Protein Binding
Yang, Y.-K., Dickinson, C. J., Zeng, Q., Li, J.-Y., Thompson, D. A., & Gantz, I. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.20.14100 · Cited by 46
Chen, M., Cai, M., Aprahamian, C. J., Georgeson, K. E., Hruby, V. J., Harmon, C. M., & Yang, Y. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702285200 · Cited by 46
Meidtner, K., Wermter, A. ‐., Hinney, A., Remschmidt, H., Hebebrand, J., & Fries, R. (2006) · Animal Genetics · doi:10.1111/j.1365-2052.2006.01414.x · Cited by 46
Tung, Y. C. L., Rimmington, D., O’Rahilly, S., & Coll, A. P. (2007) · Endocrinology · doi:10.1210/en.2007-0797 · Cited by 46
Giuliani, D., Mioni, C., Bazzani, C., Zaffe, D., Botticelli, A., Capolongo, S., Sabba, A., Galantucci, M., Iannone, A., Grieco, P., et al. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707115 · Cited by 45
Wang, C. L., Liang, L., Wang, H., Fu, J., Hebebrand, J., & Hinney, A. (2006) · Journal of Endocrinological Investigation · doi:10.1007/bf03349193 · Cited by 45
Lkhagvadorj, S., Qu, L., Cai, W., Couture, O. P., Barb, C. R., Hausman, G. J., Nettleton, D. S., Anderson, L. L., Dekkers, J. C. M., & Tuggle, C. K. (2009) · Physiological Genomics · doi:10.1152/physiolgenomics.90372.2008 · Cited by 45
Fan, W., Morrison, S. F., Cao, W.-H., & Yu, P. (2007) · Brain Research · doi:10.1016/j.brainres.2007.04.006 · Cited by 44
Donohoue, P. A., Tao, Y., Collins, M. M., Yeo, G. S. H., O’Rahilly, S., & Segaloff, D. L. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030903 · Cited by 44
Self-citationSinha, P. S., Schiöth, H. B., & Tatro, J. B. (2004) · Brain Research · doi:10.1016/j.brainres.2003.12.007 · Cited by 44
Heijboer, A. C., van den Hoek, A. M., Pijl, H., Voshol, P. J., Havekes, L. M., Romijn, J. A., & Corssmit, E. P. M. (2005) · Diabetologia · doi:10.1007/s00125-005-1838-8 · Cited by 43
Kistler‐Heer, Lauber, & Lichtensteiger (1998) · Journal of Neuroendocrinology · doi:10.1046/j.1365-2826.1998.00180.x · Cited by 43
Kosugi, S., Hai, N., Okamoto, H., Sugawa, H., & Mori, T. (2000) · European Journal of Endocrinology · doi:10.1530/eje.0.1430471 · Cited by 43
Central role of the melanocortin-4 receptors in appetite regulation after endotoxin1
Sartin, J. L., Marks, D. L., McMahon, C. D., Daniel, J. A., Levasseur, P. R., Wagner, C. G., Whitlock, B. K., & Steele, B. (2008) · Journal of Animal Science · doi:10.2527/jas.2008-0916 · Cited by 42
Schiöth, H. B., Kakizaki, Y., Kohsaka, A., Suda, T., & Watanobe, H. (2001) · Neuroreport · doi:10.1097/00001756-200103260-00014 · Cited by 42
Hawtin, S. R. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m511610200 · Cited by 42
Melanocortin potentiates leptin‐induced STAT3 signaling via MAPK pathway
Zhang, Y., Wu, X., He, Y., Kastin, A. J., Hsuchou, H., Rosenblum, C. I., & Pan, W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06144.x · Cited by 41
Rong, R., Tao, Y., Cheung, B. M. Y., Xu, A., Cheung, G. C. N., & Lam, K. S. L. (2006) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2006.02573.x · Cited by 41
Self-citationGene expression profiling of melanocortin system in neuropathic rats supports a role in nociception
Beltramo, M., Campanella, M., Tarozzo, G., Fredduzzi, S., Corradini, L., Forlani, A., Bertorelli, R., & Reggiani, A. M. (2003) · Molecular Brain Research · doi:10.1016/j.molbrainres.2003.08.001 · Cited by 40
Xiang, Z., Pogozheva, I. D., Sorenson, N. B., Wilczynski, A. M., Holder, J. R., Litherland, S. A., Millard, W. J., Mosberg, H. I., & Haskell‐Luevano, C. (2007) · Biochemistry · doi:10.1021/bi7007382 · Cited by 40
Spencer, J. D., & Schallreuter, K. U. (2008) · Endocrinology · doi:10.1210/en.2008-1212 · Cited by 40
In silico mutagenesis: a case study of the melanocortin 4 receptor
Bromberg, Y., Overton, J. D., Vaisse, C., Leibel, R. L., & Rost, B. (2009) · The FASEB Journal · doi:10.1096/fj.08-127530 · Cited by 40
Giuliani, D., Leone, S., Mioni, C., Bazzani, C., Zaffe, D., Botticelli, A. R., Altavilla, D., Galantucci, M., Minutoli, L., Bitto, A., et al. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.03.038 · Cited by 40
Wagner, C. G., McMahon, C. D., Marks, D. L., Daniel, J. A., Steele, B., & Sartin, J. L. (2004) · Neuroendocrinology · doi:10.1159/000082735 · Cited by 39
Cline, M. A., Nandar, W., Bowden, C. N., Hein, P. P., Denbow, D. M., & Siegel, P. B. (2008) · Life Sciences · doi:10.1016/j.lfs.2008.06.003 · Cited by 39
Oosterom, J., Garner, K. M., den Dekker, W. K., Nijenhuis, W. A. J., Gispen, W. H., Burbach, J. P. H., Barsh, G. S., & Adan, R. A. H. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m007261200 · Cited by 39
Dimerization of the melanocortin 4 receptor: A study using bioluminescence resonance energy transfer
Nickolls, S. A., & Maki, R. A. (2006) · Peptides · doi:10.1016/j.peptides.2004.12.037 · Cited by 36
Selkirk, J. V., Price, G. W., Nahorski, S. R., & Challiss, R. A. J. (2001) · Neuropharmacology · doi:10.1016/s0028-3908(00)00208-2 · Cited by 36
Hogan, K., Peluso, S., Gould, S., Parsons, I., Ryan, D., Wu, L., & Visiers, I. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm050780s · Cited by 36
Gao, Z., Lei, D., Welch, J., Le, K., Lin, J., Leng, S., & Duhl, D. M. J. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.055525 · Cited by 36
Paues, J., Mackerlova, L., & Blomqvist, A. G. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.03.041 · Cited by 35
Structural and signaling requirements of the human melanocortin 4 receptor for MAP kinase activation
Patten, C. S., Daniels, D., Suzuki, A., Fluharty, S. J., & Yee, D. K. (2007) · Regulatory Peptides · doi:10.1016/j.regpep.2007.02.005 · Cited by 35
Starowicz, K., Sieja, A., Bilecki, W., Obara, I., & Przewłocka, B. (2003) · Brain Research · doi:10.1016/s0006-8993(03)03444-9 · Cited by 35
Fan, Z., Sartin, J. L., & Tao, Y. (2007) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2007.05.003 · Cited by 35
Self-citationMolecular cloning and pharmacological characterization of porcine melanocortin-3 receptor
Fan, Z., Sartin, J. L., & Tao, Y. (2007) · Journal of Endocrinology · doi:10.1677/joe-07-0403 · Cited by 34
Self-citationMechanism of dimerization of the human melanocortin 1 receptor
Zanna, P. T., Sánchez‐Laorden, B. L., Pérez‐Oliva, A. B., Turpín, M. C., Herráiz, C., Jiménez‐Cervantes, C., & García-Borrón, J. C. (2008) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2008.01.060 · Cited by 34
Cragnolini, A. B., Schiöth, H. B., & Scimonelli, T. N. (2005) · Peptides · doi:10.1016/j.peptides.2005.10.020 · Cited by 33
Selkirk, J. V., Nottebaum, L. M., Lee, J., Yang, W., Foster, A. C., & Lechner, S. M. (2006) · Neuropharmacology · doi:10.1016/j.neuropharm.2006.08.015 · Cited by 33
Increased constraints on MC4R during primate and human evolution
Hughes, D. A., Hinney, A., Brumm, H., Wermter, A., Biebermann, H., Hebebrand, J., & Stoneking, M. (2008) · Human Genetics · doi:10.1007/s00439-008-0591-8 · Cited by 33
A Nonpeptide Antagonist Reveals a Highly Glycosylated State of the Rabbit Kinin B1 Receptor
Fortin, J., Dziadulewicz, E. K., Gera, L., & Marceau, F. (2006) · Molecular Pharmacology · doi:10.1124/mol.105.019976 · Cited by 33
Trevaskis, J. L., Meyer, E. A., Galgani, J. E., & Butler, A. A. (2007) · Endocrinology · doi:10.1210/en.2007-0868 · Cited by 33
da Silva, A. A., Kuo, J. J., Tallam, L. S., Liu, J., & Hall, J. E. (2005) · Hypertension · doi:10.1161/01.hyp.0000198458.70351.e0 · Cited by 33
Bertorelli, R., Fredduzzi, S., Tarozzo, G., Campanella, M., Grundy, R. I., Beltramo, M., & Reggiani, A. M. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2004.06.008 · Cited by 32
Molecular Determination of Agouti-Related Protein Binding to Human Melanocortin-4 Receptor
Yang, Y., Chen, M., Lai, Y., Gantz, I., Yağmurlu, A., Georgeson, K. E., & Harmon, C. M. (2003) · Molecular Pharmacology · doi:10.1124/mol.64.1.94 · Cited by 32
MC4R oligomerizes independently of extracellular cysteine residues
Elsner, A., Tarnow, P., Schaefer, M., Ambrugger, P., Krude, H., Grüters, A., & Biebermann, H. (2005) · Peptides · doi:10.1016/j.peptides.2005.02.027 · Cited by 31
The 103I Variant of the Melanocortin 4 Receptor Is Associated with Low Serum Triglyceride Levels
Brönner, G., Sattler, A., Hinney, A., Soufi, M., Geller, F., Schäfer, H., Maisch, B., Hebebrand, J., & Schaefer, J. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2005-0919 · Cited by 31
Adan, R. A. H. (2006) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2006.02.002 · Cited by 30
Novel melanocortin 4 receptor gene mutations in severely obese children
Lee, Y. S., Poh, L. K. S., Kek, B. L. K., & Loke, K. Y. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.03071.x · Cited by 30
A novel melanocortin-4 receptor gene mutation in a female patient with severe childhood obesity
Roth, C. L., Ludwig, M. Z., Woelfle, J., Fan, Z.-C., Brumm, H., Biebermann, H., & Tao, Y. (2009) · Endocrine · doi:10.1007/s12020-009-9156-4 · Cited by 30
Self-citationErcil, N. E., Galici, R., & Kesterson, R. A. (2005) · Psychopharmacology · doi:10.1007/s00213-005-2166-x · Cited by 29
Valli‐Jaakola, K., Palvimo, J. J., Lipsanen‐Nyman, M., Salomaa, V. V., Peltonen, L., KONTULA, K. K., & Schalin‐Jäntti, C. (2006) · Hormone Research in Paediatrics · doi:10.1159/000093469 · Cited by 29
Joppa, M. A., LING, N. C., Chen, C., Gogas, K. R., Foster, A. C., & Markison, S. (2005) · Peptides · doi:10.1016/j.peptides.2005.03.002 · Cited by 29
LICHTENSTEIGER, W., Hanimann, B., Siegrist, W., & Eberlé, A. N. (1996) · Developmental Brain Research · doi:10.1016/0165-3806(95)00167-0 · Cited by 28
Banno, R., Arima, H., Hayashi, M., Goto, M., Watanabe, M., Sato, I., Ozaki, N., Nagasaki, H., Ozaki, N., & Oiso, Y. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.02.019 · Cited by 28
Orexin Expression is Regulated by α‐Melanocyte‐Stimulating Hormone
López, M., Lage, R., Tung, Y. C. L., Challis, B., Varela, L., Virtue, S., O’Rahilly, S., Vidal‐Puig, A., Diéguez, C., & Coll, A. P. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01577.x · Cited by 28
Mutations in the Melanocortin 4 Receptor (MC4R) Gene in Obese Patients in Norway
Wangensteen, T., Kolsgaard, M. L. P., Mattingsdal, M., Joner, G., Tonstad, S., Undlien, D. E., & Retterstøl, L. (2009) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-0028-1102942 · Cited by 27
Rettenbacher, E., Tarnow, P., Brumm, H., Prayer, D., Wermter, A. ‐., Hebebrand, J., Biebermann, H., Hinney, A., & Widhalm, K. (2007) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2007-949150 · Cited by 27
Proneth, B., Xiang, Z., Pogozheva, I. D., Litherland, S. A., Gorbatyuk, O. S., Shaw, A. M., Millard, W. J., Mosberg, H. I., & Haskell‐Luevano, C. (2006) · Chemical Biology & Drug Design · doi:10.1111/j.1747-0285.2006.00362.x · Cited by 27
Mansour, M. M., White, D., Wernette, C. M., Dennis, J. C., Tao, Y., Collins, R., Parker, L. E., & Morrison, E. E. (2010) · Endocrine · doi:10.1007/s12020-009-9289-5 · Cited by 26
Self-citationFunctional Role, Structure, and Evolution of the Melanocortin‐4 Receptor
Schiöth, H. B., Lagerström, M. C., Watanobe, H., Jónsson, L., Vergoni, A. V., Ringholm, A., Skarphedinsson, J. O., Skúladóttir, G. V., Kloviņš, J., & Fredriksson, R. (2003) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2003.tb03164.x · Cited by 26
Hsiung, H. M., Hertel, J. L., Zhang, X.-Y., Smith, D. P., Smiley, D. L., Heiman, M. L., Yang, D. D., Husain, S., Mayer, J. P., Zhang, L., et al. (2005) · Endocrinology · doi:10.1210/en.2005-0177 · Cited by 26
Iqbal, J., Pompolo, S., Dumont, L. M., Wu, C., Mountjoy, K. G., Henry, B. A., & Clarke, I. J. (2001) · Neuroscience · doi:10.1016/s0306-4522(01)00250-0 · Cited by 25
Molecular Interactions of Nonpeptide Agonists and Antagonists with the Melanocortin-4 Receptor
Fleck, B. A., Chen, Yang, W., Huntley, R., Markison, S., Nickolls, S. A., Foster, A. C., & Hoare, S. R. J. (2005) · Biochemistry · doi:10.1021/bi051316s · Cited by 25
Melanocortin Receptors, Melanotropic Peptides and Penile Erection
Wessells, H., Hruby, V. J., Balse, P., & King, S. H. (2007) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026610707011111 · Cited by 25
β‐Melanocyte‐Stimulating Hormone Potently Reduces Appetite Via the Hypothalamus in Chicks
Smith, M. L., Prall, B. C., Nandar, W., & Cline, M. A. (2007) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2007.01639.x · Cited by 23
Nordheim, U., Nicholson, J. R., Dokładny, K., Dunant, P., & Hofbauer, K. G. (2005) · Peptides · doi:10.1016/j.peptides.2005.01.026 · Cited by 23
Melanocortin receptor 4 is induced in nerve‐injured motor and sensory neurons of mouse
Tanabe, K., Gamo, K., Aoki, S., Wada, K., & Kiyama, H. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2006.04432.x · Cited by 23
Beckers, S., Mertens, I. L., Peeters, A. V., Gaal, L. V., & Hul, W. V. (2005) · International Journal of Obesity · doi:10.1038/sj.ijo.0803126 · Cited by 22
Watanobe, H., Yoneda, M., Kakizaki, Y., Kohsaka, A., Suda, T., & Schiöth, H. B. (2001) · Brain Research Bulletin · doi:10.1016/s0361-9230(01)00442-7 · Cited by 22
Vergoni, A. V., Bertolini, A., Guidetti, G., Karefilakis, V., Filaferro, M., Wikberg, J., & Schiöth, H. B. (2000) · Journal of Endocrinology · doi:10.1677/joe.0.1660419 · Cited by 21
Chen, C., Tucci, F. C., Jiang, W., Tran, J. A., Fleck, B. A., Hoare, S. R. J., Wen, J., Chen, T., Johns, M. S., Markison, S., et al. (2008) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2008.03.072 · Cited by 20
Cone, R. D. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-031-5_14 · Cited by 20
Ochoa, M. C., Azcona, C., Biebermann, H., Brumm, H., Razquín, C., Wermter, A. ‐., Martínez, J. A., Hebebrand, J., Hinney, A., Moreno-Aliaga, M. J., et al. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02788.x · Cited by 20
Masuzaki, H., Tanaka, T., Ebihara, K., Hosoda, K., & Nakao, K. (2009) · Peptides · doi:10.1016/j.peptides.2009.04.008 · Cited by 20
Muceniece, R., Zvejniece, L., Vilšķe̅rsts, R., Liepinsh, E., Baumane, L., Kalvinsh, I., Wikberg, J. E. S., & Dambrova, M. (2007) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/j.1742-7843.2007.00133.x · Cited by 20
de Rijke, C. E., Jackson, P. J., Garner, K. M., van Rozen, R. J., Douglas, N. R., Kas, M. J., Millhauser, G. L., & Adan, R. A. H. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2005.04.033 · Cited by 19
Polidori, C., Geary, N., & Massi, M. (2005) · Peptides · doi:10.1016/j.peptides.2005.07.008 · Cited by 19
Kamisoyama, H., Honda, K., Saneyasu, T., Sugahara, K., & Hasegawa, S. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.041 · Cited by 19
Yang, Y., Cai, M., Chen, M., Qu, H., McPherson, D. T., Hruby, V. I., & Harmon, C. M. (2009) · Regulatory Peptides · doi:10.1016/j.regpep.2009.03.006 · Cited by 19
Tallam, L. S., Kuo, J. J., da Silva, A. A., & Hall, J. E. (2004) · Hypertension · doi:10.1161/01.hyp.0000148993.47498.b2 · Cited by 18
AgRP-deficiency could lead to increased lifespan
Redmann, S. M., & Argyropoulos, G. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.129 · Cited by 17
α-MSH and γ-MSH modulate early release of hypothalamic PGE2 and NO induced by IL-1β differently
Cragnolini, A. B., Caruso, C. M., Lasaga, M., & Scimonelli, T. N. (2006) · Neuroscience Letters · doi:10.1016/j.neulet.2006.09.034 · Cited by 16
Chen, M., Cai, M., McPherson, D. T., Hruby, V. J., Harmon, C. M., & Yang, Y. (2008) · Biochemical Pharmacology · doi:10.1016/j.bcp.2008.09.023 · Cited by 14
Melanocortin-4 receptor in sheep: A potential site for therapeutic intervention in disease models
Sartin, J. L., Wagner, C. G., Marks, D. L., Daniel, J. A., McMahon, C. D., Obese, F. Y., & Partridge, C. (2005) · Domestic Animal Endocrinology · doi:10.1016/j.domaniend.2005.02.027 · Cited by 14
MC4R Mutations—Weight before Screening!
Kublaoui, B. M., & Zinn, A. R. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0546 · Cited by 14
The melanocortin agonist melanotan II increases insulin sensitivity in OLETF rats
Banno, R., Arima, H., Sato, I., Hayashi, M., Goto, M., Sugimura, Y., Murase, T., & Oiso, Y. (2004) · Peptides · doi:10.1016/j.peptides.2004.05.007 · Cited by 11
Krishna, R., Wong, P., Stevens, C., Lepeleire, I. D., Dyck, K. V., Rosen, R. C., Gendrano, I. N., Peeters, M., Wagner, J. A., & Herman, G. A. (2008) · The Journal of Clinical Pharmacology · doi:10.1177/0091270008320925 · Cited by 10
ACTH1-24 Down-Regulates Expression of Ciliary Neurotrophic Factor mRNA in Cultured Rat Astrocyte
Kokubo, M., Asai, K., Yamamoto, N., Aoyama, M., Morikawa, M., Togari, H., Wada, Y., & Kato, T. (2002) · Pediatric Research · doi:10.1203/00006450-200212000-00022 · Cited by 9
Feeding signals to the hungry mind
Balthasar, N. (2009) · Experimental Physiology · doi:10.1113/expphysiol.2008.042226 · Cited by 7
Targeting melanocortin receptors for the treatment of obesity
Markison, S., & Foster, A. C. (2006) · Drug Discovery Today Therapeutic Strategies · doi:10.1016/j.ddstr.2006.10.011 · Cited by 7
Molecular Screening of MC4R Gene and Association with Fat Traits in Pig Resource Family
Gui, L. (2002) · Acta Genetica Sinica · Cited by 7
[Cloning and functional analysis of melanocortin 4 receptor mutation gene F261S].
Shao, X., Jia, W., Cai, S.-B., Fang, Q., Zhang, R., Lu, J., & Xiang, K. (2005) · PubMed · Cited by 6
[Molecular screening of MC4R gene and association with fat traits in pig resource family].
Liu, G.-L., Jiang, S., Xiong, Y., Zheng, R., & Qu, Y. (2002) · PubMed · Cited by 6
ACTH1-24 Down-Regulates Expression of Ciliary Neurotrophic Factor mRNA in Cultured Rat Astrocyte
KOKUBO, M. (2002) · Pediatric Research · doi:10.1203/01.pdr.0000036280.65404.f8 · Cited by 3
Flagged first, then by citations
5 of the 507 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
Obesity-Induced Hypertension: Interaction of Neurohumoral and Renal Mechanisms
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2015) · Circulation Research · doi:10.1161/circresaha.116.305697 · Cited by 1,360
Hypothalamic circuits regulating appetite and energy homeostasis: pathways to obesity
Timper, K., & Brüning, J. C. (2017) · Disease Models & Mechanisms · doi:10.1242/dmm.026609 · Cited by 851
Obesity, kidney dysfunction and hypertension: mechanistic links
Hall, J. E., do Carmo, J. M., da Silva, A. A., Wang, Z., & Hall, M. E. (2019) · Nature Reviews Nephrology · doi:10.1038/s41581-019-0145-4 · Cited by 654
Sex differences in the physiology of eating
Asarian, L., & Geary, N. (2013) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00446.2012 · Cited by 513
Emerging paradigms in GPCR allostery: implications for drug discovery
Wootten, D., Christopoulos, A., & Sexton, P. M. (2013) · Nature Reviews Drug Discovery · doi:10.1038/nrd4052 · Cited by 498
Metadata
- Authors
- Tao, Y.-X.
- Affiliations
- Auburn University (US)
- Corresponding author
- Tao, Ya-Xiong
- ORCID
- Tao, Ya-Xiong
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2010-08-01
- Volume
- 31
- Issue
- 4
- Pages
- 506-543
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- PMC
- PMC3365848
- OpenAlex
- W2120361515
- Cited by
- 531
- References
- 507
- Citations by year
- 2026: 25 · 2025: 32 · 2024: 34 · 2023: 34 · 2022: 31 · 2021: 41 · 2020: 41 · 2019: 33 · 2018: 29 · 2017: 32 · 2016: 21 · 2015: 29 · 2014: 39 · 2013: 47 · 2012: 30
- FWCI
- 16.04
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Endocrine Reviews (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (R15DK077213)
- Topics
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Keywords
- melanocortin-4 receptor, energy homeostasis, monogenic obesity, MC4R mutations, cachexia, cardiovascular function, glucose homeostasis, lipid homeostasis, drug abuse, pain perception, neuroinflammation, anxiety, receptor pharmacology, ligand binding, receptor signaling pathways, pharmacological chaperones, obesity pathogenesis, small molecule drugs
- MeSH terms
- Amino Acid Sequence, Animals, Cachexia, Cardiovascular System, Cloning, Molecular, Energy Metabolism, Gene Expression Regulation, Glucose, Homeostasis, Humans, Molecular Sequence Data, Mutation, Obesity, Organ Specificity, Reproduction, Sexual Behavior, Signal Transduction, Sequence Alignment, Receptor, Melanocortin, Type 4, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review